Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer
Clinical trial NCT02575807 · TERMINATED
Trial details
- NCT number
- NCT02575807
- Sponsor
- Aduro Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2018-04-26
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.